Federal Authority to Regulate the Compounding of Human Drugs

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service. American Law Division

Language:

English

Subjects (All):

Drugs.

Medical laws and legislation.

Product safety.

Steroids.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[United States] [publisher not identified] 2013

Summary:

Examines FDA regulation of drug compounding, which is the process of combining, mixing, or altering ingredients in order to create a medication for a particular patient. Reviews issues surrounding drug compounding, light of the 2012 fungal meningitis outbreak, believed to have been caused by a contaminated compounded steroid injection. Discusses relevant legal authorities and potential limits to FDA authority to regulate human drug compounding

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed May 2014). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. American Law Division. Federal Authority to Regulate the Compounding of Human Drugs

Publisher Number:

CRS-2013-AML-0100

Access Restriction:

Restricted for use by site license